FDA Approves First Implantable Continuous Glucose Monitor

The Eversense is implanted under the skin in a short office procedure and worn for up to 90 days.
FDA Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply